EQUITY RESEARCH MEMO
Occhem Labs
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)65/100
Occhem Labs, LLC is a US-based contract research organization (CRO) founded in 2014, specializing in custom synthesis and sourcing of small organic molecules for pre-clinical research. Serving pharmaceutical, agricultural, and biotechnology sectors, the company offers services including natural products isolation, semi-synthesis, and development of drug-like compounds and building blocks. It has developed a niche expertise in the synthesis of Vitamin K metabolites and derivatives. As a private, pre-clinical stage CRO, Occhem Labs generates revenue through service contracts rather than drug development pipelines, positioning it as a stable but moderate-growth entity in the outsourced research market.
Upcoming Catalysts (preview)
- Q3 2026Expansion of Vitamin K metabolite synthesis capabilities70% success
- Q4 2026Strategic partnership with a major pharmaceutical company40% success
- Q2 2026New ISO certification or quality accreditation85% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)